The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr. Robert Canby, a cardiac electrophysiologist, describes an FDA-approved novel lead-less system that provides cardiac ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...
Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
What Is A Biventricular Pacemaker Or A CRT Device, How Is It Implanted, And Who Is A Good Candidate?
Dr. Hunter Champion answers the question: 'What Is A Biventricular Pacemaker?' — -- Question: What is a biventricular pacemaker or cardiac resynchronization therapy (also called a CRT device), ...
BIOTRONIK’s BIO│WOMEN Study Enrolled 474 Patients Across Eight Countries in Europe and IsraelAddressing Critical Gaps as Women Often Remain Undiagnosed and Undertreated in Heart FailureThis ...
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
SAN DIEGO, CA—The observational BIO-LIBRA study, which enrolled nearly 50% women, has revealed important outcome differences by both sex and device type among patients with nonischemic cardiomyopathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results